PhRMA: Biopharmaceutical Industry Supports 81,865 Jobs in Puerto Rico

PhRMA one-pager, Puerto Rico's Economy: The Biopharmaceutical Industry Impact, October 2026.

Source: Pharmaceutical Research and Manufacturers of America (PhRMA), October 2026.

Washington, D.C. | November 17, 2026 - We are sharing new data from our friends at the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group that represents biopharmaceutical companies. PhRMA estimates that the industry supports 81,865 jobs in Puerto Rico. The numbers come from an October 2026 study that TEConomy Partners prepared for PhRMA, based on modeled 2024 estimates.

By the numbers, according to PhRMA:

  • 16,507 direct jobs in the biopharmaceutical industry

  • 65,358 more jobs in other industries that depend on it, through suppliers and worker spending

  • $69 billion in economic output

  • $1.09 billion in personal income tax revenue paid

  • 31 manufacturing plants

  • Average pay of $156,783 for direct industry jobs, compared with $43,499 across all jobs in Puerto Rico

Production roles make up the largest share of direct industry jobs at 29 percent, followed by management at 14 percent and life, physical, and social science at 12 percent.

What it means for Hispanic small businesses

For The National Puerto Rican Chamber of Commerce (NPRCC), the most important number is the second one. For every direct job at a plant, PhRMA’s model counts about four more jobs elsewhere in the economy. Many of those jobs are at the businesses that keep the plants running and serve the people who work there: suppliers, transportation and logistics firms, maintenance and repair contractors, construction, food service, and professional services. Hispanic-owned small businesses in these fields, in Puerto Rico and across the country, have a real interest in the industry’s presence on the island and in the contracting opportunities it creates.

NPRCC will keep sharing data like this so the businesses we serve can see where the opportunities are and plan for them.

About the numbers

These figures are PhRMA’s. They are modeled estimates of 2024 activity, produced with the IMPLAN economic model for a study PhRMA paid for, and they cover research, manufacturing, distribution, and corporate offices. They are not a government count.

Read the PhRMA one-pager (PDF)

See PhRMA’s state-by-state economic impact map